Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582764 · ClinicalTrials.gov registry record
Quantitative Dynamic Contrast Enhanced Breast MRI
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 116
- Enrollment target
NCT00582764: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00582764 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582764 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 116 participants
- Enrollment target
Study Summary
The purpose of this study is to see if dynamic contrast enhanced (DCE) MRI imaging makes it possible to distinguish benign conditions of the breast from malignant tumors and provide better information than can be obtained with regular MRI. DCE MRI uses a new way of collecting and analyzing the images or pictures which provides doctors extra information not available with standard imaging methods. This includes information about the blood vessels of different breast diseases. Pictures produced this way look just like the regular MRI pictures. The DCE MRI adds another imaging sequence (another scan) to the MRI examination ordered by your physician to evaluate your breast lesion, thus increasing the exam time (extra 10 min). The information gained from doing the new test, the DCE MRI, will not be used in your treatment and will not affect the type of care you receive for your breast lesions.
Interventions
- OTHER perform dynamic contrast enhanced (DCE) MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2005-09 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582764
The ClinicalTrials.gov registry entry for NCT00582764 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which perform dynamic contrast enhanced (DCE) MRI is the first listed.
NCT00582764 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00582764 about?
NCT00582764 is a clinical study titled "Quantitative Dynamic Contrast Enhanced Breast MRI". The purpose of this study is to see if dynamic contrast enhanced (DCE) MRI imaging makes it possible to distinguish benign conditions of the breast from malignant tumors and provide better information than can be obtained with regular MRI. DCE MRI uses a new way of collecting and analyzing the image...
What is the current status of trial NCT00582764?
This trial is currently completed. The enrollment target is 116 participants. The study started on 2005-09. Estimated completion is 2015-07.
What interventions are being tested in trial NCT00582764?
The interventions under investigation include: perform dynamic contrast enhanced (DCE) MRI (OTHER).
Who is sponsoring clinical trial NCT00582764?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.